Systematic Review and Meta-Analysis: Pharmacological and Nonpharmacological Interventions for Disruptive Mood Dysregulation Disorder
Journal of Child and Adolescent Psychopharmacology · 2024-06 · 34 (5) · 217-225
DOI: 10.1089/cap.2024.0013 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, online erschienen am 14.06.2024. Verfasst von Yuhan Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China. Hauptthemen laut MEDLINE: Irritable Mood, Mood Disorders. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Objectives
Disruptive mood dysregulation disorder (DMDD) is a relatively new diagnosis that comprises severe, nonepisodic irritability and recurrent outbursts of emotional instability in adolescents. This meta-analysis examined the efficacy of the available pharmacological and nonpharmacological interventions for DMDD.
Methods
Literature searches were conducted in July 2023. To determine relevant articles, 330 abstracts were reviewed, and 39 articles were identified for full review. A random-effects model was used for the meta-analysis, and a subgroup analysis was performed to assess the effects of study design and intervention type.
Results
Eleven studies were reviewed, including six pharmacological and five nonpharmacological. Despite high heterogeneity in effects ( I 2 = 85%), we showed statistically significant improvements in irritability symptoms following intervention. We showed statistically significant enhancements in symptoms of irritability following the intervention. The subgroup analysis revealed that, compared with randomized controlled trials (RCTs), open trials showed significant improvements in irritability. In addition, drug intervention significantly improved irritability compared to nondrug interventions. Atomoxetine (ATX), optimized stimulants, and stimulants combined with other drugs and behavioral therapy effectively improved irritability.
Conclusions
With research indicating potential benefits for irritability from a combination of pharmacological interventions and therapy, including ATX, stimulants in conjunction with antipsychotic or antidepressant medications, and cognitive-behavioral techniques such as Dialectical Behavior Therapy for Children. Future large-scale RCTs are essential to further explore and refine these treatment approaches, especially focusing on the efficacy of combining pharmacological with effective nonpharmacological to improve irritability and overall outcomes in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
- Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
ORCID-Profile: Yuhan Zhang
Zitieren
APA
Zhang, Y., Zhang, W., & Yu, E. (2024). Systematic Review and Meta-Analysis: Pharmacological and Nonpharmacological Interventions for Disruptive Mood Dysregulation Disorder. Journal of Child and Adolescent Psychopharmacology, 34(5), 217-225. https://doi.org/10.1089/cap.2024.0013
Vancouver
Zhang Y, Zhang W, Yu E. Systematic Review and Meta-Analysis: Pharmacological and Nonpharmacological Interventions for Disruptive Mood Dysregulation Disorder. Journal of Child and Adolescent Psychopharmacology. 2024;34(5):217-225. doi:10.1089/cap.2024.0013
BibTeX
@article{Zhang2024,
author = {Zhang, Yuhan and Zhang, Wenxuan and Yu, Enyan},
title = {Systematic Review and Meta-Analysis: Pharmacological and Nonpharmacological Interventions for Disruptive Mood Dysregulation Disorder},
journal = {Journal of Child and Adolescent Psychopharmacology},
year = {2024},
volume = {34},
number = {5},
pages = {217--225},
doi = {10.1089/cap.2024.0013}
}
EUVIMED